| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3201/EID1201.050979 |
| 10.3201/EID1209.05-0979 | ||
| P3181 | OpenCitations bibliographic resource ID | 1143889 |
| P932 | PMC publication ID | 3291398 |
| P698 | PubMed publication ID | 16494711 |
| P50 | author | Jeffery Taubenberger | Q1686423 |
| David Morens | Q67408928 | ||
| P2860 | cites work | Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic | Q22306097 |
| Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes | Q24598177 | ||
| Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene | Q24672078 | ||
| Re-emergence of fatal human influenza A subtype H5N1 disease | Q28247143 | ||
| The geography and mortality of the 1918 influenza pandemic | Q28275547 | ||
| Pandemic versus epidemic influenza mortality: a pattern of changing age distribution | Q28275622 | ||
| Characterization of the 1918 influenza virus polymerase genes | Q28275749 | ||
| Initial genetic characterization of the 1918 "Spanish" influenza virus | Q28305563 | ||
| Characterization of the 1918 "Spanish" influenza virus neuraminidase gene. | Q30326831 | ||
| World War I may have allowed the emergence of "Spanish" influenza. | Q30329986 | ||
| 1917 avian influenza virus sequences suggest that the 1918 pandemic virus did not acquire its hemagglutinin directly from birds. | Q30330646 | ||
| Characterization of the 1918 "Spanish" influenza virus matrix gene segment | Q30332027 | ||
| Relationship of pre-1918 avian influenza HA and NP sequences to subsequent avian influenza strains. | Q30336218 | ||
| 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. | Q30336398 | ||
| Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. | Q30342658 | ||
| Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. | Q30343761 | ||
| Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. | Q30344017 | ||
| A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. | Q30351248 | ||
| Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts | Q30359951 | ||
| THE INCIDENCE OF NEUTRALIZING ANTIBODIES FOR SWINE INFLUENZA VIRUS IN THE SERA OF HUMAN BEINGS OF DIFFERENT AGES | Q30382045 | ||
| The 1918 influenza virus: A killer comes into view | Q34018144 | ||
| Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid | Q34176666 | ||
| Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. | Q38344845 | ||
| Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl | Q38345108 | ||
| Antigenic similarity of influenza A(H1N1) viruses from epidemics in 1977–1978 to “Scandinavian” strains isolated in epidemics of 1950–1951 | Q39517705 | ||
| Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus | Q45561981 | ||
| The 1918 flu and other influenza pandemics: "over there" and back again | Q74587169 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| 1918-1920 flu pandemic | Q178275 | ||
| P304 | page(s) | 15-22 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Emerging Infectious Diseases | Q5235761 |
| P1476 | title | 1918 Influenza: the mother of all pandemics | |
| P478 | volume | 12 |
| Q57093570 | 100 Years of Medical Countermeasures and Pandemic Influenza Preparedness |
| Q30386677 | 1918 Influenza receptor binding domain variants bind and replicate in primary human airway cells regardless of receptor specificity. |
| Q42572727 | 1918 influenza, a puzzle with missing pieces |
| Q33571546 | 1918 influenza: a Winnebago County, Wisconsin perspective |
| Q30383437 | 2009 H1N1 influenza. |
| Q30392503 | 2009 H1N1 influenza: a twenty-first century pandemic with roots in the early twentieth century |
| Q44325178 | 2009 pandemic influenza A (H1N1), six months experience |
| Q35321520 | 3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus |
| Q30389518 | 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication |
| Q30418534 | 64 multidetector CT findings of influenza A (H1N1) virus in patients with hematologic malignancies |
| Q30379799 | A Bayesian Outbreak Detection Method for Influenza-Like Illness. |
| Q52659466 | A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody. |
| Q91638932 | A Modular Cytokine Analysis Method Reveals Novel Associations With Clinical Phenotypes and Identifies Sets of Co-signaling Cytokines Across Influenza Natural Infection Cohorts and Healthy Controls |
| Q92340053 | A Novel Fluorescent and Bioluminescent Bireporter Influenza A Virus To Evaluate Viral Infections |
| Q39397313 | A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus |
| Q93051920 | A Zoonotic Adenoviral Human Pathogen Emerged through Genomic Recombination among Human and Nonhuman Simian Hosts |
| Q30376011 | A cohort study of tuberculosis and influenza mortality in the twentieth century. |
| Q30424421 | A comprehensive analysis of reassortment in influenza A virus. |
| Q47549425 | A comprehensive study on cellular RNA editing activity in response to infections with different subtypes of influenza a viruses |
| Q30363446 | A delay differential model for pandemic influenza with antiviral treatment. |
| Q21245115 | A duplex real-time RT-PCR assay for detecting H5N1 avian influenza virus and pandemic H1N1 influenza virus |
| Q30357373 | A historical perspective of influenza A(H1N2) virus |
| Q30402288 | A model to evaluate mass vaccination against pneumococcus as a countermeasure against pandemic influenza |
| Q30383989 | A mouse model of lethal synergism between influenza virus and Haemophilus influenzae. |
| Q21245216 | A new look at an old virus: patterns of mutation accumulation in the human H1N1 influenza virus since 1918 |
| Q38802959 | A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action |
| Q39312411 | A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor |
| Q30356646 | A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severity. |
| Q98184568 | A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2 |
| Q30400507 | A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site |
| Q42562811 | A plea for caution: huge risks associated with lab-bred flu. |
| Q57112729 | A potential treatment for pandemic influenza using siRNAs targeting conserved regions of influenza A |
| Q38684843 | A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases |
| Q37148404 | A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection |
| Q61798474 | A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918-1919 |
| Q30427021 | Accumulation of CD11b⁺Gr-1⁺ cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses |
| Q30384441 | Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza. |
| Q34059472 | Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus |
| Q27005668 | Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans |
| Q27010100 | Advancements in the development of subunit influenza vaccines |
| Q64051948 | Advancing preparedness for clinical research during infectious disease epidemics |
| Q30402436 | Age as an independent risk factor for intensive care unit admission or death due to 2009 pandemic influenza A (H1N1) virus infection |
| Q30227192 | Age groups and spread of influenza: implications for vaccination strategy |
| Q30352787 | Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality |
| Q92096203 | Allergic inflammation alters the lung microbiome and hinders synergistic co-infection with H1N1 influenza virus and Streptococcus pneumoniae in C57BL/6 mice |
| Q30363346 | Allocating pandemic influenza vaccines in Minnesota: recommendations of the Pandemic Influenza Ethics Work Group. |
| Q40290149 | Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions |
| Q27326934 | An AGM model for changes in complement during pregnancy: neutralization of influenza virus by serum is diminished in late third trimester |
| Q30380435 | An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. |
| Q30385795 | An early report from newly established laboratory-based influenza surveillance in Lao PDR. |
| Q41168571 | An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus |
| Q30224564 | Analysis by single-gene reassortment demonstrates that the 1918 influenza virus is functionally compatible with a low-pathogenicity avian influenza virus in mice |
| Q37310771 | Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 |
| Q30391194 | Analytical performance determination and clinical validation of the novel Roche RealTime Ready Influenza A/H1N1 Detection Set. |
| Q27024582 | Animal models for influenza virus pathogenesis, transmission, and immunology |
| Q38043556 | Animal models in virus research: their utility and limitations |
| Q28552622 | Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding |
| Q45351626 | Anti-influenza virus effects of both live and non-live Lactobacillus acidophilus L-92 accompanied by the activation of innate immunity |
| Q30417383 | Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice |
| Q30407036 | Anticipating the species jump: surveillance for emerging viral threats |
| Q39483952 | Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice |
| Q61958131 | Antiviral Host Defence Peptides |
| Q59355986 | Antiviral activity of Poncirus trifoliata seed extract against oseltamivir-resistant influenza virus |
| Q30358429 | Antiviral agents active against influenza A viruses. |
| Q30223866 | Are we prepared to help low-resource communities cope with a severe influenza pandemic? |
| Q35922893 | Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses |
| Q33788251 | Assessment of intervention strategies against a novel influenza epidemic using an individual-based model |
| Q30407253 | Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak |
| Q56561344 | Avian Influenza A Virus Pandemic Preparedness and Vaccine Development |
| Q26765927 | Avian Influenza Viruses, Inflammation, and CD8(+) T Cell Immunity |
| Q28393914 | Avian influenza A viruses: from zoonosis to pandemic |
| Q94603315 | Avian influenza in human in Nepal: timely management and preparedness |
| Q30361041 | Avian influenza virus (H5N1): a threat to human health. |
| Q30386119 | Avian influenza--a review for doctors in travel medicine. |
| Q30359165 | Avian influenza: a review. |
| Q57817400 | Back to the Future: Lessons Learned From the 1918 Influenza Pandemic |
| Q54230741 | Baicalin Downregulates RLRs Signaling Pathway to Control Influenza A Virus Infection and Improve the Prognosis. |
| Q57093572 | Better Prepare Than React: Reordering Public Health Priorities 100 Years After the Spanish Flu Epidemic |
| Q36454402 | BioHealthBase: informatics support in the elucidation of influenza virus host pathogen interactions and virulence |
| Q37226609 | Biophysical mechanisms of the neutralization of endotoxins by lipopolyamines |
| Q38377385 | Bioseguridad in Mexico: Pursuing Security between Local and Global Biologies. |
| Q46644306 | Bird flu: what the intensivist must know |
| Q30378181 | Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. |
| Q30395270 | Breaking the HxNy outbreak |
| Q30357413 | Bringing influenza vaccines into the 21st century. |
| Q37037481 | CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination. |
| Q91838290 | COVID-19: Is a paradigm change to be expected in health care and transfusion medicine? |
| Q30406645 | Can interactions between timing of vaccine-altered influenza pandemic waves and seasonality in influenza complications lead to more severe outcomes? |
| Q58886966 | Canine influenza: should we look out for a sneeze? |
| Q30424512 | Capacity building in response to pandemic influenza threats: Lao PDR case study |
| Q35808262 | Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses |
| Q48109162 | Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure. |
| Q92970751 | Characteristics of Microbes Most Likely to Cause Pandemics and Global Catastrophes |
| Q64251291 | Characterization of Host and Bacterial Contributions to Lung Barrier Dysfunction Following Co-infection with 2009 Pandemic Influenza and Methicillin Resistant |
| Q30396719 | Charting the host adaptation of influenza viruses |
| Q28833828 | Chemical Genomics Identifies the PERK-Mediated Unfolded Protein Stress Response as a Cellular Target for Influenza Virus Inhibition |
| Q30363524 | Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential. |
| Q30411874 | Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly |
| Q51847339 | Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan. |
| Q30370424 | Clinical review: influenza pandemic - physicians and their obligations. |
| Q97424059 | Collective interactions augment influenza A virus replication in a host-dependent manner |
| Q30390147 | Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic |
| Q30394070 | Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses |
| Q30382349 | Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model. |
| Q30373950 | Computational studies of pandemic 1918 and 2009 H1N1 hemagglutinins bound to avian and human receptor analogs. |
| Q58794147 | Concurrent Conflicts—the Great War and the 1918 Influenza Pandemic |
| Q27027237 | Connecting the study of wild influenza with the potential for pandemic disease |
| Q30376366 | Conserved amino acid markers from past influenza pandemic strains. |
| Q30360137 | Conserved features of the PB2 627 domain impact influenza virus polymerase function and replication |
| Q30368757 | Contemporary avian influenza A virus subtype H1, H6, H7, H10, and H15 hemagglutinin genes encode a mammalian virulence factor similar to the 1918 pandemic virus H1 hemagglutinin. |
| Q30381376 | Controlling infectious disease outbreaks: Lessons from mathematical modelling. |
| Q30377883 | Critical review of current and emerging quantification methods for the development of influenza vaccine candidates. |
| Q30387829 | Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design |
| Q30228601 | Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain |
| Q35948250 | Cryptococcus neoformans mates on pigeon guano: implications for the realized ecological niche and globalization |
| Q30369531 | Cultural epidemiology of pandemic influenza in urban and rural Pune, India: a cross-sectional, mixed-methods study. |
| Q40147230 | Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway |
| Q38765172 | Current and future developments in the treatment of virus-induced hypercytokinemia. |
| Q39759825 | Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies |
| Q30378899 | Dating the emergence of pandemic influenza viruses |
| Q30209564 | Death from 1918 pandemic influenza during the First World War: a perspective from personal and anecdotal evidence |
| Q30429955 | Deaths associated with influenza pandemic of 1918-19, Japan |
| Q30373322 | Decentralized molecular diagnostic testing plan for pandemic influenza in the Ontario Public Health Laboratory system. |
| Q30420778 | Demographic shift of influenza A(H1N1)pdm09 during and after pandemic, rural India |
| Q30398939 | Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model |
| Q46432937 | Design and synthesis of bioactive 1,2-annulated adamantane derivatives. |
| Q90319185 | Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus |
| Q90259333 | Detection of pandemic influenza A/H1N1/pdm09 virus among pigs but not in humans in slaughterhouses in Kenya, 2013-2014 |
| Q90010544 | Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959-2016 |
| Q30407605 | Determinants of mortality in naval units during the 1918-19 influenza pandemic. |
| Q30354020 | Determinants of virulence of influenza A virus. |
| Q30391828 | Developing guidelines for school closure interventions to be used during a future influenza pandemic |
| Q38556537 | Development and applications of single-cycle infectious influenza A virus (sciIAV). |
| Q38292457 | Development of a bead-based suspension array for the detection of pathogens in acute respiratory tract infections |
| Q38645943 | Dichotomous miR expression and immune responses following primary blood-stage malaria |
| Q30375647 | Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. |
| Q64056366 | Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection |
| Q47555467 | Differential responses of innate immunity triggered by different subtypes of influenza a viruses in human and avian hosts |
| Q28479054 | Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions |
| Q36579628 | Direct sequence detection of structured h5 influenza viral RNA |
| Q47558565 | Disaster Preparedness: Biological Threats and Treatment Options |
| Q30365240 | Discovery and characterization of the 1918 pandemic influenza virus in historical context. |
| Q30395480 | Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918. |
| Q57094749 | Dissecting host cell death programs in the pathogenesis of influenza |
| Q60312958 | Docking study of flavonoid derivatives as potent inhibitors of influenza H1N1 virus neuraminidase |
| Q30355921 | Does homologous reinfection drive multiple-wave influenza outbreaks? Accounting for immunodynamics in epidemiological models. |
| Q30845053 | Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. |
| Q30402541 | Dual Recognition Element Lateral Flow Assay Toward Multiplex Strain Specific Influenza Virus Detection. |
| Q47102146 | Dynamic Regimes of El Niño Southern Oscillation and Influenza Pandemic Timing |
| Q30973428 | Early assessment of anxiety and behavioral response to novel swine-origin influenza A(H1N1). |
| Q36463645 | Early indicators of disease in ferrets infected with a high dose of avian influenza H5N1 |
| Q40138387 | Ebola epidemic exposes the pathology of the global economic and political system. |
| Q30248621 | Economic growth, urbanization, globalization, and the risks of emerging infectious diseases in China: A review |
| Q43158836 | Editorial commentary: pandemic H5N1: receding risk or coming catastrophe? |
| Q30383451 | Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic |
| Q91725040 | Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections |
| Q36422549 | Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus |
| Q30410129 | Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice |
| Q33831169 | Emergence and dynamics of influenza super-strains |
| Q64243797 | Emerging Influenza D Virus Threat: What We Know so Far! |
| Q91953848 | Emerging and reemerging respiratory viral infections up to Covid-19 |
| Q30432421 | Emerging antiviral strategies to interfere with influenza virus entry |
| Q39168387 | Emerging avian influenza infections: Current understanding of innate immune response and molecular pathogenesis |
| Q40622083 | Emerging infections - implications for dental care |
| Q90667464 | Emerging infectious disease: trends in the literature on SARS and H7N9 influenza |
| Q30227043 | Emerging, novel, and known influenza virus infections in humans. |
| Q37716213 | Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species |
| Q30414665 | Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses |
| Q30355360 | Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine. |
| Q38703697 | Enhanced production of enveloped viruses in BST-2-deficient cell lines. |
| Q57016836 | Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D |
| Q99625242 | Entry Inhibitors: Efficient Means to Block Viral Infection |
| Q30411434 | Epidemiological isolation causing variable mortality in Island populations during the 1918-1920 influenza pandemic |
| Q37087225 | Epidemiology of influenza A (H1N1)pdm09-associated deaths in the United States, September-October 2009 |
| Q27005679 | Epidemiology, ecology and gene pool of influenza A virus in Egypt: will Egypt be the epicentre of the next influenza pandemic? |
| Q93075125 | Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data |
| Q37723367 | Ethanolic Extract of Melia Fructus Has Anti-influenza A Virus Activity by Affecting Viral Entry and Viral RNA Polymerase |
| Q30418188 | Event-based internet biosurveillance: relation to epidemiological observation |
| Q64057942 | Evolution and Biological Evaluation of Matrinic Derivatives with Amantadine Fragments As New Anti-Influenza Virus Agents |
| Q90395121 | Evolution and Pathogenicity of the H1 and H3 Subtypes of Swine Influenza Virus in Mice between 2016 and 2019 in China |
| Q33707683 | Evolutionary Entropy Determines Invasion Success in Emergent Epidemics |
| Q33390357 | Evolutionary dynamics of the N1 neuraminidases of the main lineages of influenza A viruses |
| Q38107846 | Evolving gene targets and technology in influenza detection |
| Q30381981 | Excess deaths and immunoprotection during 1918-1920 influenza pandemic, Taiwan. |
| Q30226767 | Excess healthcare burden during 1918-1920 influenza pandemic in Taiwan: implications for post-pandemic preparedness |
| Q30409309 | Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong |
| Q47649799 | Excess mortality patterns during 1918-1921 influenza pandemic in the state of Arizona, USA. |
| Q40338821 | Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction |
| Q30374993 | Experimental infection of pigs with the human 1918 pandemic influenza virus |
| Q41658333 | Experimental study of the efficiency of oxidized dextran for prevention of influenza A/H5N1. |
| Q30427591 | Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses |
| Q51574720 | Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da Cunha 1971 epidemic as a case study. |
| Q30351890 | Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore. |
| Q42583813 | Ferret-transmissible influenza A(H5N1) virus: let us err on the side of caution |
| Q30148633 | Financing of international collective action for epidemic and pandemic preparedness |
| Q30384848 | First Season of 2009 H1N1 Influenza. |
| Q92990076 | Frontiers in Molecular Evolutionary Medicine |
| Q43169651 | Gene expression signatures as a therapeutic target for severe H7N9 influenza - what do we know so far? |
| Q37097035 | Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals |
| Q30361887 | Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. |
| Q36523991 | Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution |
| Q42563202 | Genome Hotspots for Nucleotide Substitutions and the Evolution of Influenza A (H1N1) Human Strains |
| Q24652550 | Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus |
| Q37366083 | Genotyping and detection of common avian and human origin-influenza viruses using a portable chemiluminescence imaging microarray |
| Q30371604 | Global burden of influenza as a cause of cardiopulmonary morbidity and mortality |
| Q30368450 | Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. |
| Q89594440 | Glucosylceramide synthase maintains influenza virus entry and infection |
| Q43101899 | Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages |
| Q40310328 | H5N1 Virus Plastic Antibody Based on Molecularly Imprinted Polymers. |
| Q30371122 | H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. |
| Q36073409 | H5N1 infects the biosecurity debate. Governments and life scientists are waking up to the problem of dual-use research |
| Q34777056 | HASP server: a database and structural visualization platform for comparative models of influenza A hemagglutinin proteins |
| Q30210097 | Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study |
| Q90616727 | Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways |
| Q30388183 | Heterogeneous and Dynamic Prevalence of Asymptomatic Influenza Virus Infections |
| Q40120272 | Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population |
| Q64100627 | Heterotypic Neuraminidase Antibodies Against Different A(H1N1) Strains are Elicited after Seasonal Influenza Vaccination |
| Q36419847 | Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade. |
| Q92089102 | Highly conserved influenza T cell epitopes induce broadly protective immunity |
| Q37336673 | Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread |
| Q59350592 | Historical and clinical aspects of the 1918 H1N1 pandemic in the United States |
| Q36594196 | Homologous recombination is very rare or absent in human influenza A virus |
| Q47097744 | Host Cell Restriction Factors that Limit Influenza A Infection. |
| Q26782795 | Host Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza Pandemic |
| Q28397046 | Host adaptation and transmission of influenza A viruses in mammals |
| Q36522870 | Host genetics of severe influenza: from mouse Mx1 to human IRF7 |
| Q30369075 | How World War 1 changed global attitudes to war and infectious diseases |
| Q30362207 | How integration of global omics-data could help preparing for pandemics - a scent of influenza. |
| Q30377316 | Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses. |
| Q30391411 | Human Influenza Virus Infections |
| Q64075893 | Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11 |
| Q31133429 | Human-Animal Interface: The Case for Influenza Interspecies Transmission |
| Q40142497 | IL-33: a jack of all trades in the orchestration of respiratory antibacterial immunity |
| Q96767111 | Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells |
| Q34979139 | Identification of putative interactions between swine and human influenza A virus nucleoprotein and human host proteins |
| Q37799532 | Identifying genetic markers of adaptation for surveillance of viral host jumps |
| Q30411189 | Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender |
| Q30401669 | Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection |
| Q30399272 | Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. |
| Q30430741 | Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States |
| Q64916134 | Impact of the 1918 Influenza Pandemic in Coastal Kenya. |
| Q66680369 | In vivo analysis of influenza A mRNA secondary structures identifies critical regulatory motifs |
| Q30385011 | Incorporating explicit ethical reasoning into pandemic influenza policies. |
| Q33418589 | Increased susceptibility for superinfection with Streptococcus pneumoniae during influenza virus infection is not caused by TLR7-mediated lymphopenia |
| Q30427835 | Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. |
| Q63246245 | Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response |
| Q28678578 | Infectious disease emergence and global change: thinking systemically in a shrinking world |
| Q34244882 | Inference of genotype-phenotype relationships in the antigenic evolution of human influenza A (H3N2) viruses. |
| Q30372317 | Inference of seasonal and pandemic influenza transmission dynamics. |
| Q35839143 | Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice |
| Q90668531 | Influence of extreme weather and meteorological anomalies on outbreaks of influenza A (H1N1) |
| Q36154939 | Influencing Busy People in a Social Network. |
| Q30381366 | Influenza A (H1N1) 2009: a pandemic alarm. |
| Q37424992 | Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation |
| Q40774367 | Influenza A and methicillin-resistant Staphylococcus aureus co-infection in rhesus macaques - A model of severe pneumonia. |
| Q35762999 | Influenza A viral replication is blocked by inhibition of the inositol-requiring enzyme 1 (IRE1) stress pathway. |
| Q37098830 | Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis. |
| Q30367880 | Influenza A virus isolation, culture and identification |
| Q30397203 | Influenza A virus transmission: contributing factors and clinical implications |
| Q30423112 | Influenza A(H1N1)pdm09: beyond the pandemic. |
| Q50208606 | Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation |
| Q30379090 | Influenza Circulation in United States Army Training Camps Before and During the 1918 Influenza Pandemic: Clues to Early Detection of Pandemic Viral Emergence |
| Q90486818 | Influenza Infections and Emergent Viral Infections in Intensive Care Unit |
| Q34150283 | Influenza Vaccines for the Future |
| Q40084055 | Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis. |
| Q30410842 | Influenza activity in Saint Joseph, Missouri 1910-1923: Evidence for an early wave of the 1918 pandemic. |
| Q30354157 | Influenza and endemic viral pneumonia. |
| Q30406641 | Influenza and pneumonia mortality in 66 large cities in the United States in years surrounding the 1918 pandemic |
| Q40042164 | Influenza hemagglutinin attachment to target cells: 'birds do it, we do it...' |
| Q47331095 | Influenza immunization policies: Which could be the main reasons for differences among countries? |
| Q51453971 | Influenza in Children. |
| Q30423910 | Influenza in pregnancy |
| Q30391993 | Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic |
| Q84148467 | Influenza influences ion channels |
| Q37962433 | Influenza pandemics |
| Q30229146 | Influenza pandemics in Singapore, a tropical, globally connected city |
| Q22305643 | Influenza pandemics of the 20th century |
| Q90744284 | Influenza pandemics: past, present and future challenges |
| Q30397030 | Influenza surveillance in Shenzhen, the largest migratory metropolitan city of China, 2006-2009. |
| Q30366650 | Influenza vaccines to control influenza-associated bacterial infection: where do we stand? |
| Q38444279 | Influenza virus polymerase: Functions on host range, inhibition of cellular response to infection and pathogenicity. |
| Q30411865 | Influenza viruses: from birds to humans |
| Q64129863 | Influenza-Related Communication and Community Mitigation Strategies: Results From the 2015 Pandemic Influenza Readiness Assessment |
| Q30368552 | Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts. |
| Q28596741 | Influenza: from zoonosis to pandemic |
| Q24630177 | Influenza: the once and future pandemic |
| Q64916529 | Information Hazards in Biotechnology. |
| Q30151464 | Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway |
| Q33646273 | Innate immune evasion strategies of influenza viruses |
| Q37226509 | Innate immune modulation by RNA viruses: emerging insights from functional genomics |
| Q30407187 | Insights on influenza pathogenesis from the grave |
| Q92071347 | Insulin-Like Growth Factor 1 Regulates Acute Inflammatory Lung Injury Mediated by Influenza Virus Infection |
| Q30382373 | Interaction of the role of Concentrated Animal Feeding Operations (CAFOs) in Emerging Infectious Diseases (EIDS). |
| Q37768935 | Interspecies and intraspecies transmission of influenza A viruses: viral, host and environmental factors |
| Q95271433 | Interventional Radiology Preparedness in the Time of the COVID-19 Pandemic: Is there a Gold Standard? |
| Q34837288 | Intra-host diversities of the receptor-binding domain of stork faeces-derived avian H5N1 viruses and its significance as predicted by molecular dynamic simulation |
| Q35960723 | Invasion thresholds and the evolution of nonequilibrium virulence |
| Q56433322 | Invasive life, communities of practice, and communities of fate |
| Q30379956 | Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs. |
| Q47922829 | Is there a case for mandating influenza vaccination in healthcare workers? |
| Q30430036 | Isolation and Phylogenetic Analysis of H1N1 Swine Influenza Virus from Sick Pigs in Southern China |
| Q47336884 | Keeping Pace with the Red Queen: Identifying the Genetic Basis of Susceptibility to Infectious Disease. |
| Q97079023 | Learning cytology in times of pandemic: an educational institutional experience with remote teaching |
| Q30396868 | Lessons from the swine flu: pandemic, panic and/or pandemonium? |
| Q30422861 | Lessons learned from the 1918-1919 influenza pandemic |
| Q89844364 | Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases |
| Q59353949 | Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency |
| Q34404965 | Linking influenza virus tissue tropism to population-level reproductive fitness |
| Q36014611 | Lost in the world of functional genomics, systems biology, and translational research: is there life after the Milstein award? |
| Q42592367 | Managing public health crises: the role of models in pandemic preparedness |
| Q37916778 | Mass spectrometry based proteomic studies on viruses and hosts--a review |
| Q57250056 | Mathematical analysis of an influenza epidemic model, formulation of different controlling strategies using optimal control and estimation of basic reproduction number |
| Q42789427 | Maximizing the value of drug stockpiles for pandemic influenza |
| Q30369085 | Mechanical ventilation in an airborne epidemic. |
| Q51884452 | Mechanistic modelling of the three waves of the 1918 influenza pandemic |
| Q30385683 | Modelling seasonality and viral mutation to predict the course of an influenza pandemic. |
| Q30359683 | Modulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis. |
| Q30422857 | Molecular character of influenza A/H1N1 2009: Implications for spread and control |
| Q30361874 | Molecular characterization of circulating pandemic strains of influenza A virus during 2012 to 2013 in Lucknow (India). |
| Q61818388 | Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons |
| Q30227995 | Molecular detection of a novel human influenza (H1N1) of pandemic potential by conventional and real-time quantitative RT-PCR assays |
| Q35989071 | Molecular docking based screening of neem-derived compounds with the NS1 protein of Influenza virus |
| Q30377243 | Mortality burden of the 1918-1919 influenza pandemic in Europe |
| Q42425424 | Mortality burden of the 1918-1920 influenza pandemic in Hong Kong. |
| Q30421831 | Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic |
| Q24643173 | Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study |
| Q30426197 | Mortality from the influenza pandemic of 1918-19 in Indonesia |
| Q30417502 | Mortality from the influenza pandemic of 1918-1919: the case of India |
| Q60730908 | Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 |
| Q21089624 | Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918 |
| Q28535330 | Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals |
| Q64234959 | Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions |
| Q41929893 | Mutually cooperative epidemics on power-law networks |
| Q37166751 | N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes |
| Q90215071 | Natality Decline and Spatial Variation in Excess Death Rates During the 1918-1920 Influenza Pandemic in Arizona, United States |
| Q97075306 | Neurological associations of COVID-19 |
| Q30429431 | New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain |
| Q30228906 | Nonpharmaceutical Interventions for Military Populations During Pandemic Influenza. |
| Q58798213 | Novel Flu Viruses in Bats and Cattle: "Pushing the Envelope" of Influenza Infection |
| Q52599675 | Novel Platforms for the Development of a Universal Influenza Vaccine. |
| Q30382312 | Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. |
| Q30378285 | Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. |
| Q52670500 | On the Regularities of the Polar Profiles of Proteins Related to Ebola Virus Infection and their Functional Domains. |
| Q95319947 | Oncology Nursing During a Pandemic: Critical Reflections in the Context of COVID-19 |
| Q30197053 | Opinion: Specimen collections should have a much bigger role in infectious disease research and response |
| Q30368332 | Origin of the 1918 Spanish influenza virus: a comparative genomic analysis. |
| Q24647063 | Origins of the Spanish Influenza pandemic (1918-1920) and its relation to the First World War |
| Q30224096 | Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review |
| Q36593645 | Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks |
| Q33720358 | Outpatient physician billing data for age and setting specific syndromic surveillance of influenza-like illnesses |
| Q59350372 | Packaging of the influenza A virus genome is governed by a plastic network of RNA/protein interactions |
| Q30386315 | Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. |
| Q30228856 | Pandemic and seasonal influenza: therapeutic challenges |
| Q30389319 | Pandemic influenza (H1N1) 2009 is associated with severe disease in India |
| Q30409529 | Pandemic influenza and health system resource gaps in Bali: an analysis through a resource transmission dynamics model. |
| Q59135891 | Pandemic influenza preparedness in the WHO African region: are we ready yet? |
| Q30408091 | Pandemic influenza vaccines - the challenges |
| Q30379060 | Pandemic influenza--including a risk assessment of H5N1 |
| Q30404256 | Pandemic influenza: certain uncertainties |
| Q30377856 | Pandemic influenza: impact on perianesthesia nursing areas. |
| Q28390930 | Pandemic influenza: implications for preparation and delivery of critical care services |
| Q112593815 | Pandemics, tourism and global change: a rapid assessment of COVID-19 |
| Q30420391 | Pandemism of swine flu and its prospective drug therapy |
| Q30374152 | Parapneumonic empyema deaths during past century, Utah. |
| Q36384299 | Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries |
| Q64098563 | Particle velocity controls phase transitions in contagion dynamics |
| Q30367936 | Passive broad-spectrum influenza immunoprophylaxis |
| Q30413158 | Passive immune neutralization strategies for prevention and control of influenza A infections |
| Q64991783 | Pathobiological features favouring the intercontinental dissemination of highly pathogenic avian influenza virus. |
| Q30412566 | Pathogenic responses among young adults during the 1918 influenza pandemic. |
| Q39534931 | Patient-Reported Outcome Assessments as Endpoints in Studies in Infectious Diseases |
| Q58301484 | Persistence and transmission of avian influenza A (H5N1): virus movement, risk factors and pandemic potential |
| Q30390922 | Perspectives on influenza evolution and the role of research |
| Q51164805 | Phylodynamic applications in 21st century global infectious disease research. |
| Q30228181 | Plagues in the ICU: a brief history of community-acquired epidemic and endemic transmissible infections leading to intensive care admission |
| Q57108698 | Planning for a pandemic: a view from the accident and emergency department |
| Q57092554 | Poliomyelitis era in Trinidad from 1940 to 1972 and beyond: Implications for effective global health governance for its eradication |
| Q41546580 | Political will and international collaborative frameworks in infectious diseases |
| Q41935985 | Poor outcomes among elderly patients hospitalized for influenza like illness |
| Q35884766 | Population-based active surveillance cohort studies for influenza: lessons from Peru |
| Q51121028 | Population-level effects of suppressing fever. |
| Q29248089 | Postviral Complications: Bacterial Pneumonia |
| Q30355037 | Potential impact of pandemic influenza on blood safety and availability. |
| Q28382815 | Predicting 'airborne' influenza viruses: (trans-) mission impossible? |
| Q30414153 | Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. |
| Q24647318 | Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness |
| Q37679627 | Prevalence and correlates of influenza-A in piggery workers and pigs in two communities in Lagos, Nigeria |
| Q39770895 | Principles underlying rational design of live attenuated influenza vaccines |
| Q30389578 | Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9. |
| Q30369896 | Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. |
| Q30407650 | Prospects for controlling future pandemics of influenza |
| Q30385271 | Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. |
| Q47130066 | Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines |
| Q38225146 | Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development |
| Q37127965 | Proteolytic activation of the 1918 influenza virus hemagglutinin |
| Q30384713 | Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic. |
| Q33831152 | Public health interventions for epidemics: implications for multiple infection waves |
| Q30389099 | Public preferences for vaccination programmes during pandemics caused by pathogens transmitted through respiratory droplets - a discrete choice experiment in four European countries, 2013. |
| Q30227373 | Public preparedness guidance for a severe influenza pandemic in different countries: a qualitative assessment and critical overview |
| Q30385165 | Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections |
| Q42176996 | Punctuated evolution of influenza virus neuraminidase (A/H1N1) under opposing migration and vaccination pressures |
| Q36712763 | Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century |
| Q30364985 | Quantifying social distancing arising from pandemic influenza. |
| Q91725707 | Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review |
| Q30396665 | Rapid detection of pandemic influenza in the presence of seasonal influenza. |
| Q40140330 | Rapid virulence shift of an H5N2 avian influenza virus during a single passage in mice. |
| Q30230428 | Real-time epidemic forecasting for pandemic influenza |
| Q36781320 | Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection |
| Q38076422 | Recombinant influenza vaccines. |
| Q30421157 | Reconstruction of the 1918 influenza virus: unexpected rewards from the past |
| Q7310435 | Reinventing Discovery: The New Era of Networked Science |
| Q26746999 | Replication-Competent Influenza A Viruses Expressing Reporter Genes |
| Q35755496 | Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens |
| Q30226999 | Research preparedness paves the way to respond to pandemic H1N1 2009 influenza virus |
| Q28079922 | Respiratory viral infections and host responses; insights from genomics |
| Q96111213 | Resuming elective surgery in the time of COVID-19: a safe and comprehensive strategy |
| Q28076140 | Reverse Genetics Approaches for the Development of Influenza Vaccines |
| Q30227298 | Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza |
| Q37073335 | Robust Lys63-Linked Ubiquitination of RIG-I Promotes Cytokine Eruption in Early Influenza B Virus Infection |
| Q30374894 | Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. |
| Q30397858 | Rules of co-occurring mutations characterize the antigenic evolution of human influenza A/H3N2, A/H1N1 and B viruses |
| Q94591141 | SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis) |
| Q99612881 | SARS-CoV-2 infection in India bucks the trend: Trained innate immunity? |
| Q30376021 | School closure may be effective in reducing transmission of respiratory viruses in the community. |
| Q47149561 | Scientific Opinion on monitoring for the emergence of possible new pandemic strains of influenza in animals |
| Q45122002 | Seasonality in risk of pandemic influenza emergence |
| Q30403507 | Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans |
| Q30352182 | Secondary bacterial infections in patients with seasonal influenza A and pandemic H1N1. |
| Q91705219 | Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production |
| Q52657377 | Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections. |
| Q40680147 | Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients. |
| Q30397001 | Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes |
| Q64980748 | Sex ratios at birth vary with environmental harshness but not maternal condition. |
| Q90326256 | Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness |
| Q99721377 | Short-term and long-term health impacts of air pollution reductions from COVID-19 lockdowns in China and Europe: a modelling study |
| Q91941845 | Situation analysis and an insight into assessment of pandemic COVID-19 |
| Q29013327 | Social contexts, syndemics, and infectious disease in northern Aboriginal populations |
| Q30362170 | Spanish influenza in Japanese armed forces, 1918-1920. |
| Q89433017 | Spanish influenza redux: revisiting the mother of all pandemics |
| Q57093562 | Spatio-Temporal Patterns and Diffusion of the 1918 Influenza Pandemic in British India |
| Q30368376 | Spatio-temporal investigation of the 1918 influenza pandemic in military populations indicates two different viruses |
| Q30217197 | State of the art in risk analysis of workforce criticality influencing disaster preparedness for interdependent systems |
| Q30375111 | Stockpiling drugs for an avian influenza outbreak: examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemic |
| Q28297557 | Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans |
| Q36253747 | Structural Basis for a Novel Interaction between the NS1 Protein Derived from the 1918 Influenza Virus and RIG-I. |
| Q27660330 | Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus |
| Q64058331 | Structural Insights for Anti-Influenza Vaccine Design |
| Q55627667 | Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization. |
| Q93084241 | Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine |
| Q28396120 | Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies |
| Q43174858 | Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season. |
| Q51783731 | Swine Flu: Knowledge, Attitude, and Practices Survey of Medical and Dental Students of Karachi. |
| Q57723245 | Swine flu and hype: a systematic review of media dramatization of the H1N1 influenza pandemic |
| Q30402300 | Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis? |
| Q33452123 | Symbiont genomics, our new tangled bank |
| Q30399993 | Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection. |
| Q92661632 | Synthesis and Biological Evaluation of NH2-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors |
| Q84104357 | Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial |
| Q24650817 | Synthetic viruses: a new opportunity to understand and prevent viral disease |
| Q100559126 | Systematic analysis of infectious disease outcomes by age shows lowest severity in school-age children |
| Q30401654 | Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009 |
| Q30375496 | TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. |
| Q30379943 | Testing the Fetal Origins Hypothesis in a developing country: evidence from the 1918 Influenza Pandemic. |
| Q30404855 | The 'Russian' influenza in the UK: lessons learned, opportunities missed |
| Q58555463 | The 100-plus Study of cognitively healthy centenarians: rationale, design and cohort description |
| Q30382370 | The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice |
| Q59351183 | The 1918 Influenza pandemic in Montevideo: the southernmost capital city in the Americas |
| Q30404858 | The 1918 influenza pandemic in Florianopolis: a subtropical city in Brazil |
| Q30356329 | The 1918 influenza pandemic in New York City: age-specific timing, mortality, and transmission dynamics. |
| Q30227352 | The 1918 influenza pandemic: lessons for 2009 and the future |
| Q30390380 | The 2009 A (H1N1) influenza virus pandemic: A review |
| Q88667823 | The 2009 A(H1N1) pandemic in Europe: A review of the experience |
| Q87461595 | The 2019 Coronavirus: Learning Curves, Lessons, and the Weakest Link |
| Q97521801 | The Anatomic Pathology laboratory adjustments in the era of COVID-19 pandemic: The experience of a laboratory in a Portuguese central hospital |
| Q91872624 | The COVID-19 pandemic: implications for the cytology laboratory |
| Q95600630 | The COVID‐19 pandemic: Is it a “Black Swan”? Some risk management challenges in common with chemical process safety |
| Q90285296 | The Chiropractic Vertebral Subluxation Part 4: New Perspectives and Theorists From 1916 to 1927 |
| Q30376527 | The Effectiveness of Age-Specific Isolation Policies on Epidemics of Influenza A (H1N1) in a Large City in Central South China |
| Q91729703 | The Establishment and Validation of the Human U937 Cell Line as a Cellular Model to Screen Immunomodulatory Agents Regulating Cytokine Release Induced by Influenza Virus Infection |
| Q30377136 | The Genomic Contributions of Avian H1N1 Influenza A Viruses to the Evolution of Mammalian Strains. |
| Q35974128 | The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells |
| Q100417691 | The Impact of a Six-Year Climate Anomaly on the "Spanish Flu" Pandemic and WWI |
| Q57093565 | The Mother of All Pandemics Is 100 Years Old (and Going Strong)! |
| Q64063954 | The PB2 Polymerase Host Adaptation Substitutions Prime Avian Indonesia Sub Clade 2.1 H5N1 Viruses for Infecting Humans |
| Q30392368 | The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymerase |
| Q57093843 | The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses |
| Q27673499 | The Protein Maker: an automated system for high-throughput parallel purification |
| Q90706788 | The Role of Innate Leukocytes during Influenza Virus Infection |
| Q30393294 | The Role of Radiology in Influenza: Novel H1N1 and Lessons Learned From the 1918 Pandemic |
| Q64103684 | The Spanish Influenza Pandemic: a lesson from history 100 years after 1918 |
| Q30358216 | The Spanish flu in Uppsala, clinical and epidemiological impact of the influenza pandemic 1918-1919 on a Swedish county. |
| Q30385805 | The Spanish influenza pandemic in occidental Europe (1918-1920) and victim age. |
| Q30399889 | The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding |
| Q28732491 | The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions |
| Q40689926 | The antiviral effects of acteoside and the underlying IFN-γ-inducing action |
| Q27008860 | The changing face of pathogen discovery and surveillance |
| Q64227333 | The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo |
| Q34039460 | The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics |
| Q36459143 | The cytokine storm of severe influenza and development of immunomodulatory therapy |
| Q92518169 | The effect of mutations derived from mouse-adapted H3N2 seasonal influenza A virus to pathogenicity and host adaptation |
| Q30398146 | The emergence of pandemic influenza viruses |
| Q43174720 | The emergence of the novel H1N1 virus: implications for global mental health |
| Q47555634 | The emerging influenza virus threat: status and new prospects for its therapy and control. |
| Q39922634 | The enigma of the H1N1 flu: are you ready? |
| Q30372984 | The ethics of care: social workers in an influenza pandemic. |
| Q36557808 | The evolution of human influenza A viruses from 1999 to 2006: a complete genome study |
| Q30366966 | The evolution of pandemic influenza: evidence from India, 1918-19. |
| Q24649077 | The genomic and epidemiological dynamics of human influenza A virus |
| Q27656676 | The hemagglutinin structure of an avian H1N1 influenza A virus |
| Q37011494 | The human/animal interface: emergence and resurgence of zoonotic infectious diseases |
| Q30397758 | The impact of mass gatherings and holiday traveling on the course of an influenza pandemic: a computational model. |
| Q30360440 | The impact of prophylaxis of healthcare workers on influenza pandemic burden. |
| Q91609376 | The impending storm: COVID-19, pandemics and our overwhelmed emergency departments |
| Q38050084 | The importance of understanding the human-animal interface : from early hominins to global citizens |
| Q35589073 | The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study |
| Q37996924 | The influence of pregnancy on systemic immunity |
| Q36024446 | The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure |
| Q30227531 | The influenza A(H1N1) epidemic in Mexico. Lessons learned |
| Q30403251 | The influenza pandemic of 2009: lessons and implications |
| Q42222394 | The inhibitory effect of iridoid glycoside extracted from Fructus Gardeniae on intracellular acidification and extracellular Ca2+ influx induced by influenza A virus |
| Q93038719 | The matrix segment of the "Spanish flu" virus originated from intragenic recombination between avian and human influenza A viruses |
| Q30422474 | The modes of evolutionary emergence of primal and late pandemic influenza virus strains from viral reservoir in animals: an interdisciplinary analysis |
| Q42256838 | The multifaceted effect of PB1-F2 specific antibodies on influenza A virus infection |
| Q37305747 | The need to include animal protection in public health policies |
| Q30387513 | The new influenza A H1N1 virus: balancing on the interface of humans and animals |
| Q30389809 | The new pandemic influenza A/(H1N1)pdm09 virus: is it really "new"? |
| Q30361519 | The next influenza pandemic: can it be predicted? |
| Q64258914 | The origins of the great pandemic |
| Q30230496 | The pandemic influenza threat: a review from the primary care perspective. |
| Q22255608 | The pathology of influenza virus infections |
| Q37359858 | The persistent legacy of the 1918 influenza virus |
| Q30366265 | The prospect of pandemic influenza: why should the optometrist be concerned about a public health problem? |
| Q30419838 | The relationship between tuberculosis and influenza death during the influenza (H1N1) pandemic from 1918-19. |
| Q92665374 | The relative effects of determinants on Chinese adults' decision for influenza vaccination choice: What is the effect of priming? |
| Q37207159 | The role of RNA folding free energy in the evolution of the polymerase genes of the influenza A virus |
| Q30424181 | The role of cellular immunity in influenza H1N1 population dynamics |
| Q38240678 | The role of influenza in the severity and transmission of respiratory bacterial disease |
| Q28082144 | The role of viral, host, and secondary bacterial factors in influenza pathogenesis |
| Q28750491 | The shifting demographic landscape of influenza |
| Q30386197 | The shifting demographic landscape of pandemic influenza. |
| Q30417409 | The time required to estimate the case fatality ratio of influenza using only the tip of an iceberg: joint estimation of the virulence and the transmission potential |
| Q54213423 | The unusually diverse mortality patterns in the Pacific region during the 1918-21 influenza pandemic: reflections at the pandemic's centenary |
| Q36298475 | Theoretical investigation on the binding specificity of sialyldisaccharides with hemagglutinins of influenza A virus by molecular dynamics simulations |
| Q30222430 | Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae |
| Q30362112 | Time variations in the transmissibility of pandemic influenza in Prussia, Germany, from 1918-19. |
| Q42257424 | Timely estimates of influenza A H7N9 infection severity |
| Q30376840 | Towards a sane and rational approach to management of Influenza H1N1 2009. |
| Q37035833 | Traditional and new influenza vaccines |
| Q43175399 | Transforming schools into pre-designed alternative care sites as part of preparedness plan for pandemic H5N1 influenza. |
| Q30227380 | Transmissibility of the 1918 pandemic influenza in Montreal and Winnipeg of Canada |
| Q99578601 | Transport policymaking that accounts for the COVID-19 and future public health threats: A PASS approach |
| Q26748906 | Treatment and Prevention of Pandemic H1N1 Influenza |
| Q30354730 | Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice |
| Q37423910 | Understanding influenza backward |
| Q30379209 | Understanding influenza transmission, immunity and pandemic threats |
| Q30399494 | Understanding mortality in the 1918-1919 influenza pandemic in England and Wales |
| Q30396482 | Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines |
| Q30363382 | Up to new tricks - a review of cross-species transmission of influenza A viruses. |
| Q45383836 | Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. |
| Q30363963 | Use of functional genomics to understand influenza-host interactions. |
| Q30421562 | Vaccination against influenza: role and limitations in pandemic intervention plans |
| Q92564603 | Vaccine Evolution and Its Application to Fight Modern Threats |
| Q37298594 | Vaccine chronicle in Japan |
| Q57471126 | Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness |
| Q37616752 | Vaccines for military use. |
| Q30413059 | Viral reassortment as an information exchange between viral segments |
| Q30223401 | Virulence attenuation during an influenza A/H5N1 pandemic |
| Q30398168 | Virulence determinants of pandemic influenza viruses |
| Q30391709 | Visual analytics of geo-social interaction patterns for epidemic control |
| Q59259330 | Voluntary vaccination: the pandemic effect |
| Q57898191 | Waves of El Niño-Southern Oscillation and Influenza Pandemics |
| Q30391133 | Web-based self-triage of influenza-like illness during the 2009 H1N1 influenza pandemic |
| Q42590872 | Welcome to microbial informatics and experimentation |
| Q30353639 | Why did many more diamond miners than gold miners die in South Africa during the 1918 influenza pandemic? |
| Q37461770 | ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways |
| Q91901498 | Zoonoses in the Emergence of Human Viral Diseases |
| Q51842256 | [Pandemic potential of circulating avian influenza strains sharing common features with the 1918 influenza strain]. |
| Q94556126 | [The 2020 Corona Pandemic-Beyond Omnipresent Prevention] |
| Q55011885 | miR-21-3p Regulates Influenza A Virus Replication by Targeting Histone Deacetylase-8. |
| Q42904862 | pH1N1 influenza A: Timing is everything* |
Search more.